tiprankstipranks
Trending News
More News >

Srinivas Akkaraju Insider Profile

25 Followers
Srinivas Akkaraju, Director at ZS Pharma, holds 6.35M shares in Alumis Inc. (Ticker: ALMS), holds 12.95M shares in Kalaris Therapeutics (Ticker: KLRS), holds 6.92M shares in Scholar Rock Holding (Ticker: SRRK). Most recently, Srinivas Akkaraju Bought ― shares of Alumis Inc. on Jan 13, 2026 for an estimated value of $10.00M.
tipranks
Srinivas Akkaraju

Srinivas Akkaraju
ZS Pharma (ZSPH)
Director

Ranked #1,483 out of 105,518 Corporate Insiders

Profitable Transactions

49%
17 out of 35 Profitable Transactions

Average Return

+32.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$805M
38.07%
25.51%
19.33%
15.77%
1.33% Others
A breakdown of Srinivas Akkaraju's holdings

Insider Roles

Scholar Rock Holding
(SRRK)
Director
Mineralys Therapeutics, Inc.
(MLYS)
Director
Alumis Inc.
(ALMS)
Director
Kalaris Therapeutics
(KLRS)
Director, Ten Percent Owner
+2 other positions
Roles that Srinivas Akkaraju holds in companies

Most Profitable Insider Trade

Stock:
Alumis Inc.
(ALMS)
Rating:Informative Buy
Date:May 06, 2025 - Today
Return:+317.90%
The most profitable trade made by Srinivas Akkaraju

Srinivas Akkaraju's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ZSPH
ZS Pharma
Dec 21, 2015
Uninformative Sell
90.00K
$0.00
Syros Pharmaceuticals
Sep 18, 2024
Director
Uninformative Buy
5.28K
$177.33
PRNB
Principia Biopharma
Sep 20, 2018
Uninformative Buy
$38.37M
KDNY
Chinook Therapeutics
Aug 11, 2023
Uninformative Sell
$0.00
JYAC
Jiya Acquisition
Scholar Rock Holding
Dec 16, 2025
Director
Informative Buy
1.18M
$306.43M
Mineralys Therapeutics, Inc.
Sep 08, 2025
Director
Informative Buy
15.00M
$205.31M
vTv Therapeutics
Sep 25, 2025
Director
Uninformative Buy
1.62M
$10.67M
Alumis Inc.
Jan 13, 2026
Director
Informative Buy
10.00M
$155.58M
Kalaris Therapeutics
Dec 22, 2025
Director, Ten Percent Owner
Uninformative Buy
15.00M
$126.89M
ARAV
Aravive
Dec 02, 2019
Informative Buy
1000.00K
$24.32K
ICPT
Intercept Pharma
May 25, 2023
Uninformative Buy
$13.05M
SGEN
Seagen
May 19, 2020
Uninformative Buy
$9.49M
GEVA
Synageva
Jun 28, 2012
Informative Sell
13.60M
List of latest transactions for each holding click on a transaction to see Srinivas Akkaraju's performance on stock

Srinivas Akkaraju insider profile FAQ

What is the percentage of profitable transactions made by Srinivas Akkaraju?
The percentage of profitable transactions made by Srinivas Akkaraju is 49%.
    What is the average return per transaction made by Srinivas Akkaraju?
    The average return per transaction made by Srinivas Akkaraju is 32.30%.
      What stocks does Srinivas Akkaraju hold?
      Srinivas Akkaraju holds: ZSPH, SYRS, PRNB, KDNY, JYAC, SRRK, MLYS, VTVT, ALMS, KLRS, ARAV, ICPT, SGEN, GEVA stocks.
        What was Srinivas Akkaraju’s latest transaction?
        Srinivas Akkaraju latest transaction was an Informative Buy of $10.00M.
          What was Srinivas Akkaraju's most profitable transaction?
          Srinivas Akkaraju’s most profitable transaction was an Informative Buy of ALMS stock on May 6, 2025. The return on the trade was 317.90%.
            What is Srinivas Akkaraju's role in ZS Pharma?
            Srinivas Akkaraju's role in ZS Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.